Navigation Links
American Society for Microbiology honors Nicholas J. White
Date:8/19/2009

The 2009 American Society for Microbiology (ASM) sanofi-aventis ICAAC Award will be presented to Nicholas J. White, Professor, University of Oxford, United Kingdom and Mahidol University, Bangkok, and Chair, Wellcome Trust South East Asian Research Units, Bangkok. Supported by sanofi-aventis, the award has honored outstanding accomplishment in antimicrobial chemotherapy, development of new agents, investigation of antimicrobial action or resistance to antimicrobial agents, and/or the pharmacology, toxicology or clinical use of those agents since 1982.

Dr. White has spent his career working on the prevention and treatment of malaria. His early research showed that pharmacokinetics can differ between groups and between those with and without malaria. This observation resulted in the guiding of current recommendations for the dosing of antimalarials. His subsequent work with colleagues demonstrated the incredible effectiveness of artemisinin, a traditional Chinese-plant derived antimalarial, in uncomplicated and severe falciparum malaria. They showed that adding a new drug was not sufficient and that monotherapy with artemisinin would likely lead to the spread of resistant parasites. Their observation led to the formulation of the artemisinin-based combination treatments (ACT) which is endorsed by the World Health Organization as the first line treatment for falciparum malaria worldwide. Furthermore, their research showed that artemisinin derivatives reduce malaria transmissibility. His work has been one of the major drivers of the marked decrease in malaria morbidity seen in over a dozen countries this decade.

Dr. White received his MB, BS, M.D., and D.Sc. Medicine from the University of London.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/11/2016)... , March 11, 2016 ... new market research report "Image Recognition Market by Technology ... (Marketing and Advertising), by Deployment Type (On-Premises and Cloud), ... To 2022", published by MarketsandMarkets, the global market is ... to USD 29.98 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... manufacturing company, today announced several positive developments that position the Company for the ... result of the transaction, Craig F. Kinghorn has been appointed Chairman of the ...
(Date:5/25/2016)... ... 2016 , ... Founder of the Fitzmaurice Hand Institute in ... of the hand by the National Board of Physicians and Surgeons, as of ... in his pursuit of providing the most comprehensive, effective treatment for his patients, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. ... the company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar ... FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is ...
(Date:5/23/2016)... ... ... need for blood donations in South Texas and across the nation is growing. , But ... blood donations are on the decline. In fact, donations across the country are at their ... Texas in the last four years alone. , There is no substitute for blood. , ...
Breaking Biology Technology: